News

Dr. Bassaganya-Riera, Landos Chairman & CEO, Provides Corporate and Clinical Update

Read More

Landos Biopharma Announces Final Safety Results from Phase I Study of BT-11 in Healthy Volunteers

Read More

First Human Dosing of BT-11 Announced

Read More

New Data from Landos Biopharma

Read More

Landos Featured in Life Science Leader

Read More

Landos Biopharma Recently Featured in BioCentury

Read More